TATA INDIA PHARMA & HEALTHCARE FUND holds 39 instruments (99.13% equity), led by Sun Pharmaceutical Industries Limited (8.59%), Divi's Laboratories Limited (6.36%) and Healthcare Global Enterprises Limited (5.85%), as of its 31 July 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of TATA INDIA PHARMA & HEALTHCARE FUND, managed by Tata Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 39 instruments with an equity allocation of 99.13%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
TATA INDIA PHARMA & HEALTHCARE FUND's top 10 holdings account for 52.74% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 92.16% of net assets, spread across 3 sectors in total. Since its 30 June 2026 disclosure, the fund added 5 new positions and exited 2 positions, with Max Healthcare Institute Limited seeing the largest move (-1.61pp to 4.07%).
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Divi's Laboratories Limited | 5.12% → 6.36% | ▲ +1.24 |
| Abbott India Limited | 4.97% → 5.63% | ▲ +0.66 |
| Procter & Gamble Health Limited | 1.79% → 2.42% | ▲ +0.63 |
| Sumitomo Chemical India Limited | 0.97% → 1.59% | ▲ +0.62 |
| Pfizer Limited | 2.5% → 3.06% | ▲ +0.56 |
| GlaxoSmithKline Pharmaceuticals Limited | 4.12% → 4.66% | ▲ +0.54 |
| Dr. Lal Path Labs Ltd. | 1.64% → 2.17% | ▲ +0.53 |
| Rainbow Childrens Medicare Limited | 4.42% → 4.9% | ▲ +0.48 |
| Sai Life Sciences Limited | 2.53% → 2.89% | ▲ +0.36 |
| Healthcare Global Enterprises Limited | 5.52% → 5.85% | ▲ +0.33 |
| Stock | Weight | Change |
|---|---|---|
| Max Healthcare Institute Limited | 5.68% → 4.07% | ▼ -1.61 |
| Sanofi India Limited | 1.53% → 0.23% | ▼ -1.3 |
| Mankind Pharma Limited | 3.85% → 3.02% | ▼ -0.83 |
| Apollo Hospitals Enterprise Limited | 4.61% → 3.9% | ▼ -0.71 |
| Neuland Laboratories Limited | 1.6% → 1.25% | ▼ -0.35 |
| Metropolis Healthcare Limited | 1.45% → 1.12% | ▼ -0.33 |
| Cipla Limited | 4.77% → 4.53% | ▼ -0.24 |
| Fortis Healthcare Limited | 3.35% → 3.12% | ▼ -0.23 |
| Global Health Limited | 2.32% → 2.13% | ▼ -0.19 |
| Lupin Limited | 2.81% → 2.64% | ▼ -0.17 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: Tata Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.